BREAKING   3NT Medical wins FDA clearance for drivable Peregrine sinus endoscope STUDY   Peregrine viewed 100% of frontal & sphenoid sinuses vs 45% for a 4mm rigid scope FIRST   Colibri billed as the world's first single-use endoscope built for otology BACKING   Optics giant Hoya leads $15M round - its first venture bet in Israel BREAKING   3NT Medical wins FDA clearance for drivable Peregrine sinus endoscope STUDY   Peregrine viewed 100% of frontal & sphenoid sinuses vs 45% for a 4mm rigid scope FIRST   Colibri billed as the world's first single-use endoscope built for otology BACKING   Optics giant Hoya leads $15M round - its first venture bet in Israel
Company Dossier · Medical Devices · Otolaryngology

3NT Medical.

The Israeli medtech building sterile, single-use endoscopes purpose-built for the ear, nose, and throat.

ROSH HA'AYIN, ISRAEL  /  FOUNDED 2012  /  BACKED BY HOYA

3NT Medical logo

THE MARK. The 3NT Medical wordmark - three letters for the three domains of ENT: ear, nose, and throat.

2012
Founded
2
FDA-Cleared Scopes
$15M+
Raised
100%
Sinus View (Study)
The Story

A scope built for the anatomy, not borrowed from it

For years, ear, nose, and throat surgeons worked with rigid endoscopes designed for other parts of the body. 3NT Medical set out to change the tool itself.

3NT Medical is a medical device company that makes sterile, single-use endoscopes purpose-built for otolaryngologists - the surgeons who treat the ear, nose, and throat. Its name is a nod to the three domains of ENT, and its pitch is refreshingly narrow: rather than adapt general-purpose scopes, build ones shaped around the specific, awkward anatomy of the sinus and the ear.

The company was founded in 2012 in Rosh Ha'ayin, Israel, by brothers Ehud Bendory, who serves as CEO, and Eran Bendory, its CTO. It runs research and development from Israel and commercial operations from Short Hills, New Jersey. Today it is a compact team of roughly 16 people.

What 3NT Medical sells is a consumable, not a capital machine. Each scope arrives sterile in a pouch, is used for a single procedure, and is discarded. That design choice removes two persistent headaches in surgical endoscopy: the cost and delay of reprocessing multi-use devices, and the cross-contamination risk that reprocessing can leave behind.

Both of the company's products - the Colibri Micro ENT Scope and the drivable Peregrine Sinus Endoscope - carry U.S. FDA 510(k) clearance and European CE marking, the two regulatory credentials that let a device reach patients in its largest markets.

"Assessing the sinuses from a distance is now a thing of the past."
Ehud Bendory - Co-Founder & CEO, 3NT Medical
The Problem & The Customer

See more, cut less

In ENT surgery, the disease often hides in narrow, angled spaces a straight rigid scope cannot reach - forcing surgeons to remove healthy tissue just to get a look.

The customers are otolaryngologists and the hospitals and ambulatory surgical centers where they operate. Their core frustration is access: the frontal, sphenoid, and maxillary sinuses sit behind narrow openings and sharp turns, and standard rigid endoscopes see only a fraction of them without additional resection. In the ear, the working corridor is measured in millimeters, and every extra instrument competes for space.

3NT Medical's answer is to bend and steer where a rigid scope stays straight. That lets a surgeon inspect intra-sinus anatomy with minimal resection - preserving soft tissue - and, in the ear, to work with both hands using a single device that also carries suction. The clinical promise is simple to state and hard to engineer: reach the disease, spare the healthy tissue around it.

Products

Two scopes, two anatomies

A focused portfolio - one built for the ear, one built to fly into the sinus.

Colibri Micro ENT Scope

Otology · FDA Cleared 2020

Described as the world's first single-use endoscope purpose-built for otology. It pairs a lightweight, ergonomic handpiece with a 2.2mm-diameter tip and built-in suction, so a surgeon can perform two-handed endoscopic ear procedures with one sterile device - no reprocessing between patients.

Peregrine Drivable ENT Scope

Sinus · FDA Cleared 2021

A single-use, drivable sinus scope with a 2.3mm tip the surgeon can angulate sharply and then advance in the direction of the turn - all with one hand. Named for the falcon, it is built to dive into narrow nasal anatomy and view deep intra-sinus disease that rigid scopes miss.

The Evidence

What the surgeon can actually see

In a comparative study, the drivable Peregrine visualized far more of each sinus than a conventional 4mm rigid endoscope.

Sinus visualization: Peregrine vs 4mm rigid scope

% of each sinus visualized in comparative study
Frontal
Peregrine 100%
Rigid 45.3%
Sphenoid
Peregrine 100%
Rigid 53.3%
Maxillary
Peregrine 97.1%
Rigid 39.4%
Peregrine drivable scope4mm rigid endoscope
Business & Market

The disposable bet

3NT Medical runs a B2B consumable model. It manufactures and sells single-use scopes to hospitals and surgical centers, earning revenue per procedure rather than through one-time sales of expensive reusable equipment. That aligns the company with the broader industry shift toward single-use endoscopy, driven by infection-control pressure and the true cost of reprocessing.

What sets it apart is specialization. Where large incumbents - Karl Storz, Olympus, Stryker - sell broad lines of reusable rigid scopes, 3NT Medical builds a narrow set of devices shaped for exactly two ENT jobs, adding maneuverability (Peregrine's steerable tip) and integration (Colibri's built-in suction) that a general-purpose rigid scope does not offer.

Where it fits

  • Single-use endoscopy - a growing segment inside the ENT device market
  • Competes against reprocessed multi-use rigid scopes as the status-quo alternative
  • Backed by Hoya, giving it optics and medtech depth beyond its size
  • R&D in Israel, commercial base in the U.S. Northeast
  • Regulatory footprint: FDA 510(k) + CE mark on both products
Timeline

The road so far

2012

3NT Medical is founded

Brothers Ehud and Eran Bendory start the company in Israel to build ENT-specific endoscopes.

2018

Hoya leads a ~$15M round

The Japanese optics maker backs 3NT Medical in what was reported as its first venture investment in an Israeli company.

2020

Colibri cleared by the FDA

The Colibri Micro ENT Scope earns 510(k) clearance, billed as the world's first single-use endoscope built for otology.

2021

Peregrine cleared by the FDA

The single-use, drivable Peregrine Sinus Endoscope earns clearance for deep intra-sinus access.

The File

Facts & figures

Achievements

  • FDA 510(k) clearance for Colibri (2020) - first single-use otology scope
  • FDA 510(k) clearance for the drivable Peregrine sinus scope (2021)
  • Study: Peregrine saw 100% of frontal & sphenoid, 97.1% of maxillary sinus
  • Secured Hoya's first Israeli venture investment
  • CE marking on both product lines for Europe

Fun facts

  • "3NT" nods to the three domains of ENT - ear, nose, throat
  • Peregrine is named after the fastest animal on Earth
  • Founded and led by two brothers, Ehud and Eran Bendory
  • Hoya broke its own pattern to make 3NT its first Israeli bet
Questions

The quick briefing

What does 3NT Medical make?
Sterile, single-use endoscopes purpose-built for ENT surgeons - currently the Colibri Micro ENT Scope for otology and the Peregrine Drivable Sinus Endoscope.
Who founded 3NT Medical and when?
It was founded in 2012 by brothers Ehud Bendory (CEO) and Eran Bendory (CTO) in Israel.
What makes the Peregrine endoscope different?
It is a single-use scope with a 2.3mm tip the surgeon can steer with one hand, reaching and viewing deep intra-sinus anatomy. In a study it visualized far more of the sinuses than a standard 4mm rigid scope.
Are 3NT Medical's devices approved?
Yes - both the Colibri and Peregrine scopes have FDA 510(k) clearance in the U.S. and carry CE marking in Europe.
Who backs 3NT Medical?
Japanese optics and medical technology company Hoya led its roughly $15M financing round, reported as Hoya's first venture investment in an Israeli company.

Share this dossier